{"id":"https://openalex.org/W4282015982","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.9545","title":"Glycoproteomics as a powerful liquid biopsy-based predictor of checkpoint inhibitor treatment benefit in metastatic malignant melanoma.","display_name":"Glycoproteomics as a powerful liquid biopsy-based predictor of checkpoint inhibitor treatment benefit in metastatic malignant melanoma.","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4282015982","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.9545"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.16_suppl.9545","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.9545","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.9545","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060041987","display_name":"Klaus Lindpaintner","orcid":"https://orcid.org/0000-0002-6923-4900","observed_orcids":["https://orcid.org/0000-0002-6923-4900"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Klaus Lindpaintner","raw_affiliation_strings":["InterVenn, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"InterVenn, South San Francisco, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013441259","display_name":"Alan Mitchell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alan Mitchell","raw_affiliation_strings":["InterVenn Biosciences, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"InterVenn Biosciences, South San Francisco, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074866369","display_name":"Chad Pickering","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chad Pickering","raw_affiliation_strings":["InterVenn Biosciences, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"InterVenn Biosciences, South San Francisco, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034426117","display_name":"Gege Xu","orcid":"https://orcid.org/0000-0002-0792-2636","observed_orcids":["https://orcid.org/0000-0002-0792-2636"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gege Xu","raw_affiliation_strings":["Venn Biosciences Corporation, Redwood City, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Venn Biosciences Corporation, Redwood City, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057469496","display_name":"Kimberly Vigal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kimberly Vigal","raw_affiliation_strings":["InterVenn Biosciences, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"InterVenn Biosciences, South San Francisco, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052846325","display_name":"Bianca C. Axenfeld","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bianca Axenfeld","raw_affiliation_strings":["InterVenn Biosciences, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"InterVenn Biosciences, South San Francisco, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060182527","display_name":"Rachel A. Rice","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rachel Rice","raw_affiliation_strings":["InterVenn, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"InterVenn, South San Francisco, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025010102","display_name":"Cong Xin","orcid":"https://orcid.org/0000-0002-6513-7097","observed_orcids":["https://orcid.org/0000-0002-6513-7097"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xin Cong","raw_affiliation_strings":["InterVenn, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"InterVenn, South San Francisco, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047185974","display_name":"Dennie Tompers Frederick","orcid":"https://orcid.org/0000-0003-3355-5267","observed_orcids":["https://orcid.org/0000-0003-3355-5267"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dennie T. Frederick","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090589359","display_name":"William A. Michaud","orcid":"https://orcid.org/0000-0002-3664-2094","observed_orcids":["https://orcid.org/0000-0002-3664-2094"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William Michaud","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009222009","display_name":"Genevieve Marie Boland","orcid":"https://orcid.org/0000-0002-7522-6173","observed_orcids":["https://orcid.org/0000-0002-7522-6173"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Genevieve Marie Boland","raw_affiliation_strings":["Massachusetts General Hospital, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Houston, TX;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073630820","display_name":"Danie Serie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Danie Serie","raw_affiliation_strings":["Venn Biosciences Corporation, Redwood City, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Venn Biosciences Corporation, Redwood City, CA;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"16_suppl","first_page":"9545","last_page":"9545"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10602","display_name":"Glycosylation and Glycoproteins Research","score":0.8169000148773193,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10602","display_name":"Glycosylation and Glycoproteins Research","score":0.8169000148773193,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.17100000381469727,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10519","display_name":"Advanced Proteomics Techniques and Applications","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/1607","display_name":"Spectroscopy"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glycoproteomics","display_name":"glycoproteomics","score":0.9449999928474426},{"id":"https://openalex.org/keywords/liquid-biopsy","display_name":"liquid biopsy","score":0.902999997138977},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.8180000185966492},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9549999833106995},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.6819999814033508},{"id":"https://openalex.org/keywords/serum-proteins","display_name":"serum proteins","score":0.5529999732971191},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.7210000157356262},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.9089999794960022},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":1.0},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9559999704360962},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.6890000104904175},{"id":"https://openalex.org/keywords/glycosylation","display_name":"glycosylation","score":0.718999981880188},{"id":"https://openalex.org/keywords/post-translational-modification","display_name":"post-translational modification","score":0.6389999985694885}],"concepts":[{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.7627469301223755},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.739470362663269},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.6647173762321472},{"id":"https://openalex.org/C156534840","wikidata":"https://www.wikidata.org/wiki/Q5572649","display_name":"Glycoproteomics","level":4,"score":0.6275172829627991},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.49348390102386475},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.47734764218330383},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4762073755264282},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47463831305503845},{"id":"https://openalex.org/C137610392","wikidata":"https://www.wikidata.org/wiki/Q2425020","display_name":"Glycopeptide","level":3,"score":0.47038426995277405},{"id":"https://openalex.org/C206212055","wikidata":"https://www.wikidata.org/wiki/Q2553138","display_name":"Glycan","level":3,"score":0.2947051525115967},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.25173771381378174},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.21806693077087402},{"id":"https://openalex.org/C108625454","wikidata":"https://www.wikidata.org/wiki/Q187126","display_name":"Glycoprotein","level":2,"score":0.13217997550964355},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09548428654670715},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.07815921306610107},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.16_suppl.9545","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.9545","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.9545","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3180995031","https://openalex.org/W4388084815","https://openalex.org/W4308376814","https://openalex.org/W4380611623","https://openalex.org/W4362594169","https://openalex.org/W4282961677","https://openalex.org/W4286296421","https://openalex.org/W4321329184","https://openalex.org/W4393092637","https://openalex.org/W3101423203"],"abstract_inverted_index":{"9545":[0],"Background:":[1],"Protein":[2],"glycosylation":[3,32],"is":[4],"the":[5,26,41,73,80,166,182,218,223],"most":[6],"abundant":[7],"and":[8,21,46,145,172,176,245,295],"complex":[9],"form":[10],"of":[11,25,29,44,79,104,165,181,203,207,222,226,231,255,272,286,301],"post-translational":[12],"protein":[13,18,31],"modification.":[14],"Glycosylation":[15],"profoundly":[16],"affects":[17],"structure,":[19],"conformation,":[20],"function.":[22],"The":[23],"elucidation":[24],"potential":[27],"role":[28],"differential":[30],"as":[33,168,323],"biomarkers":[34],"has":[35,269],"so":[36],"far":[37],"been":[38],"limited":[39],"by":[40,185],"technical":[42],"complexity":[43],"generating":[45],"interpreting":[47],"this":[48,84,342],"information.":[49],"We":[50],"have":[51],"recently":[52],"established":[53],"a":[54,64,102,169,190,197,229,234,270,284,320,324],"novel,":[55],"powerful":[56],"platform":[57],"that":[58,70,195,317,331],"combines":[59],"liquid":[60],"chromatography/mass":[61],"spectrometry":[62],"with":[63,117,123,153,159],"proprietary":[65],"artificial-intelligence-based":[66],"data":[67],"processing":[68],"engine":[69],"allows,":[71],"for":[72,193,201,237,326],"first":[74],"time":[75],"highly":[76],"scalable":[77],"interrogation":[78],"glycoproteome.":[81],"Methods:":[82],"Using":[83,163],"platform,":[85],"we":[86,149,188],"interrogated":[87],"526":[88],"glycopeptide":[89,175],"(GP)":[90],"signatures":[91],"derived":[92],"from":[93,101,242,250],"75":[94],"serum":[95],"proteins":[96],"in":[97,217,303,341],"pretreatment":[98],"blood":[99],"samples":[100],"cohort":[103,167],"205":[105],"individuals":[106],"(66":[107],"females,":[108],"139":[109],"males,":[110],"age":[111],"range":[112],"24":[113],"to":[114,161,275,290,298,311,333],"97":[115],"years)":[116],"metastatic":[118],"malignant":[119],"melanoma":[120],"treated":[121],"either":[122],"nivolumab":[124],"plus":[125],"ipilimumab":[126],"(95":[127],"patients)":[128,132],"or":[129],"pembrolizumab":[130],"(110":[131],"immune-checkpoint":[133],"inhibitor":[134,328],"(ICI)":[135],"therapy.":[136],"Results:":[137],"In":[138],"an":[139],"optimized":[140],"assay":[141],"containing":[142],"27":[143],"glycopeptides":[144],"20":[146],"non-glycosylated":[147,177],"peptides,":[148],"identified":[150],"14":[151],"GPs":[152],"abundance":[154],"differences":[155],"at":[156,209,233,283],"FDR":[157],"q\u22640.05":[158],"regard":[160],"PFS.":[162],"40%":[164],"training":[170],"set":[171,220],"selecting":[173],"12":[174],"peptide":[178],"biomarker":[179,339],"features":[180],"47":[183],"total":[184],"LASSO":[186],"shrinkage,":[187],"created":[189],"multivariable-model-based":[191],"classifier":[192,214,263,268],"PFS":[194,254],"yielded":[196],"hazard":[198],"ratio":[199],"(HR)":[200],"prediction":[202],"likely":[204,240,247,277],"ICI":[205,243,251,278],"benefit":[206,330],"7.5":[208],"p":[210],"<":[211],"0.0001.":[212],"This":[213,267],"was":[215],"validated":[216],"test":[219],"comprised":[221],"held-out":[224],"60%":[225],"patients,":[227],"yielding":[228],"HR":[230],"4.7":[232],"similar":[235],"p-value":[236],"separating":[238],"patients":[239],"benefiting":[241,249],"therapy":[244,252],"those":[246],"not":[248],"(50%":[253],"18":[256],"months":[257,260],"vs.":[258],"3":[259],"based":[261],"on":[262],"score":[264],"above/below":[265],"cutoff).":[266],"sensitivity":[271],">":[273],"99%":[274],"predict":[276],"benefit,":[279],"while":[280],"still":[281],"performing":[282],"specificity":[285],"26%,":[287],"thus":[288],"helping":[289],"safely":[291],"reduce":[292],"ultimately":[293],"unnecessary":[294],"non-beneficial":[296],"exposure":[297],"these":[299],"agents":[300],"one":[302],"four":[304],"who":[305],"otherwise":[306],"would":[307],"unnecessarily":[308],"be":[309],"exposed":[310],"them.":[312],"Conclusions:":[313],"Our":[314],"results":[315],"indicate":[316],"glycoproteomics":[318],"holds":[319],"strong":[321],"promise":[322],"predictor":[325],"checkpoint":[327],"treatment":[329],"appears":[332],"significantly":[334],"outperform":[335],"other":[336],"currently":[337],"pursued":[338],"approaches":[340],"context.":[343]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2022-06-13T00:00:00"}